Cresset Asset Management LLC reduced its stake in Haleon plc (NYSE:HLN - Free Report) by 76.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,897 shares of the company's stock after selling 163,280 shares during the quarter. Cresset Asset Management LLC's holdings in Haleon were worth $486,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also recently made changes to their positions in the business. FMR LLC raised its stake in shares of Haleon by 3.7% during the fourth quarter. FMR LLC now owns 108,827,814 shares of the company's stock worth $1,038,217,000 after acquiring an additional 3,909,545 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Haleon by 67.5% during the fourth quarter. Wellington Management Group LLP now owns 15,328,325 shares of the company's stock worth $146,232,000 after acquiring an additional 6,175,835 shares in the last quarter. Envestnet Asset Management Inc. raised its stake in shares of Haleon by 0.8% during the fourth quarter. Envestnet Asset Management Inc. now owns 7,630,307 shares of the company's stock worth $72,793,000 after acquiring an additional 58,444 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Haleon by 18.3% during the fourth quarter. JPMorgan Chase & Co. now owns 6,014,903 shares of the company's stock worth $57,382,000 after acquiring an additional 930,701 shares in the last quarter. Finally, Northern Trust Corp raised its stake in shares of Haleon by 27.7% during the fourth quarter. Northern Trust Corp now owns 5,412,542 shares of the company's stock worth $51,636,000 after acquiring an additional 1,172,931 shares in the last quarter. 6.67% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research firms have commented on HLN. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price target on the stock in a research note on Friday, May 9th. HSBC reissued a "hold" rating on shares of Haleon in a research note on Wednesday, March 5th. Barclays restated an "overweight" rating on shares of Haleon in a report on Tuesday, May 6th. Deutsche Bank Aktiengesellschaft restated a "hold" rating on shares of Haleon in a report on Monday, March 3rd. Finally, Hsbc Global Res cut shares of Haleon from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. Five equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Haleon has a consensus rating of "Moderate Buy" and a consensus target price of $11.25.
Get Our Latest Report on HLN
Haleon Stock Down 0.3%
Shares of Haleon stock opened at $10.42 on Thursday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. Haleon plc has a 52-week low of $8.25 and a 52-week high of $10.85. The stock has a market capitalization of $47.00 billion, a price-to-earnings ratio of 30.65, a P/E/G ratio of 2.82 and a beta of 0.24. The company's 50 day moving average price is $10.21 and its 200-day moving average price is $9.85.
Haleon (NYSE:HLN - Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The business had revenue of $3.54 billion for the quarter, compared to analysts' expectations of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. Equities research analysts forecast that Haleon plc will post 0.43 EPS for the current year.
Haleon Increases Dividend
The business also recently declared a -- dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be issued a $0.1166 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a yield of 1.6%. This is a boost from Haleon's previous -- dividend of $0.05. Haleon's payout ratio is 58.97%.
Haleon Company Profile
(
Free Report)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.